Hata T, Ikeda M, Miyata H, et al. Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese National Clinical Database (516 217 cases). Ann Gastroenterol Surg. 2019;3:534--543. 10.1002/ags3.12275

1. INTRODUCTION {#ags312275-sec-0005}
===============

Venous thromboembolism (VTE) is a well‐recognized, common surgical complication in European countries. The incidence of fatal VTE ranges from 0.1% to 0.8%.[1](#ags312275-bib-0001){ref-type="ref"} However, a recent survey indicated that the age‐adjusted mortality rate from VTE markedly increases.[2](#ags312275-bib-0002){ref-type="ref"} According to a recent study in Japan, VTE occurred in 24.3% of patients undergoing abdominal surgery, including asymptomatic cases.[3](#ags312275-bib-0003){ref-type="ref"} This result shows that the incidence of VTE in Japan is not inferior in comparison with Western countries.

The risk of VTE differs across various patient and disease factors and types of operation. The risk of VTE is highest during the initial period after the diagnosis of malignancy.[4](#ags312275-bib-0004){ref-type="ref"} VTE, including asymptomatic cases, occurs in up to 20% of cancer patients and is one of the leading causes of death in patients with cancer.[5](#ags312275-bib-0005){ref-type="ref"}, [6](#ags312275-bib-0006){ref-type="ref"} VTE is a potentially fatal but preventable complication after major gastroenterological surgery for cancer.[7](#ags312275-bib-0007){ref-type="ref"} However, the incidence of symptomatic VTE is very low during the operation, requiring a large sample size to detect risk factors in detail.

The National Surgical Quality Improvement Program (NSQIP) of the American College of Surgeons provides practical and real‐time clinical data about surgical risks to surgeons.[8](#ags312275-bib-0008){ref-type="ref"}, [9](#ags312275-bib-0009){ref-type="ref"} On the other hand, in Japan the National Clinical Database (NCD), a nationwide project that is linked to the surgical board certification, started patient registration in January 2011.[10](#ags312275-bib-0010){ref-type="ref"}, [11](#ags312275-bib-0011){ref-type="ref"} This prospective, multicenter clinical registry was created to provide feedback on risk‐adjusted outcomes to hospitals and surgeons for quality improvement purposes. This system covers more than 90% of general surgeries performed in Japan, with 9 690 000 patients from more than 5100 hospitals registered each year.

The NCD collects reliable and validated data, including demographics, laboratory results, comorbidities, and postoperative outcomes for patients undergoing a range of surgeries in Japan. In this study, using the NCD system, we identified the risk factors for perioperative VTE for patients undergoing gastroenterological surgeries.

2. METHODS {#ags312275-sec-0006}
==========

2.1. Patient selection (data collection) {#ags312275-sec-0007}
----------------------------------------

Japan\'s NCD is a nationwide project in cooperation with the certification board of the Japan Surgical Society. From January 2011, data for more than 9 690 000 patients undergoing surgery were collected from more than 5100 hospitals registered each year. Information about operations performed nationwide was registered in the NCD by data management departments from the participating institutions (<http://www.ncd.or.jp/>). The data were evaluated annually using a web‐based data management system to assure data traceability.[12](#ags312275-bib-0012){ref-type="ref"} This system also validates data consistency by inspecting randomly chosen institutions.

The NCD is continuously updated by data management departments from participating institutions and is evaluated annually using an internet‐based data management system to ensure data quality. Current laws, ordinances, and guidelines regarding the confidentiality of data are observed. Patients agree to have their data included in research projects by using presumed consent with opt‐out through the Web page and/or a notice at each hospital.

In this study, we used eight gastroenterological procedures (gastrectomy, total gastrectomy, hepatectomy, esophagectomy, right hemicolectomy, low anterior resection, pancreaticoduodenectomy, and acute pan‐peritonitis surgery) data. Because these data were determined to represent the performance of surgery in each specialty, the input of detailed items such as laboratory data and operative morbidities was requested.

Within these procedures, there were 382 124 cases between 2011 and 2013 and 134 093 cases in 2014. We used data between 2011 and 2013 as a test set to develop the prediction model and data from 2014 as a validation set.

2.2. Endpoint {#ags312275-sec-0008}
-------------

The primary objective was to investigate the frequency of VTE and pulmonary embolism (PE) in actual clinical practice from data in the NCD. A secondary objective was to identify the risk factors for perioperative VTE and PE.

2.3. Prediction model development {#ags312275-sec-0009}
---------------------------------

We developed two different risk models for predicting postoperative VTE. One used pre‐ and intra‐operative factors. In the other model, postoperative factors were added. PE was analyzed separately using a similar approach.

Univariate analysis was done using Fisher\'s exact test and the two‐tailed *t* test. In the development of the dataset, we built multivariable logistic regression models using a forward step‐wise selection of predictors with a *P *=* *0.05 for entry and *P *=* *0.10 for exit.

Basically, in cross‐tabulation with the responding outcome, variables that were \<0.2 and variables that seem to be clinically significant even if some *P* \> 0.2 were added.

Even if these were a similar event, we used the combination of categories that were logically consistent and clinically relevant from a clinical point of view.

We assessed the models' performances by applying the predictor to the validation dataset and evaluating its ability to discriminate between the presence and absence of VTE or PE using the C‐index, which reflects the area under the receiver operating characteristic (ROC) curve for VTE or PE. A ROC curve is a plot of a test\'s true‐positive rate (sensitivity) versus its false‐positive rate (1 ‐ specificity). Each point on the ROC curve indicates a pair of false‐ and true‐positive rates that is achieved using a particular threshold to dichotomize the predicted probabilities. All statistical analyses were performed using SPSS (version 21; IBM Corp., Armonk, NY, USA). This study was approved by the institutional review board of Japan Surgical Society.

3. RESULTS {#ags312275-sec-0010}
==========

3.1. Incidence of DVT and PE {#ags312275-sec-0011}
----------------------------

The incidence of deep vein thrombosis (DVT) and PE associated with the eight gastroenterological procedures are shown in Table [1](#ags312275-tbl-0001){ref-type="table"}.

###### 

Incidence of VTE between 2011 and 2013 (NCD data, gastroenterological) (N = 382 124)

  Operation                       n             Pulmonary embolism (%)   n             Deep vein thrombosis (%)
  ------------------------------- ------------- ------------------------ ------------- --------------------------
  Gastrectomy                     93/101 481    0.10                     123/101 481   0.12
  Total gastrectomy               82/57 997     0.14                     116/57 997    0.20
  Hepatectomy                     58/23 489     0.25                     99/23 489     0.42
  Esophagectomy                   43/16 556     0.26                     93/16 556     0.56
  Right hemicolectomy             68/59 246     0.11                     134/59 246    0.23
  Low anterior resection          61/51 632     0.12                     113/51 632    0.22
  Pancreaticoduodenectomy         62/26 668     0.23                     103/26 668    0.39
  Acute pan‐peritonitis surgery   86/27 377     0.31                     203/27 377    0.74
  Total                           553/382 124   0.14                     984/382 124   0.26

Abbreviations: NCD, National Clinical Database; VTE, venous thromboembolism.
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In the NCD data, PE was diagnosed by dynamic computed tomography (CT) scan, pulmonary arteriography, or by pulmonary blood flow scintigrams within 30 days after surgery. DVT was diagnosed by dynamic CT scan or duplex scan within 30 days after surgery. The incidence rate of DVT associated with the eight surgical procedures was between 0.1% and 0.7%.

The highest incidence rate (0.7%) was seen with acute pan‐peritonitis surgery followed by esophagectomy (0.6%). The incidence of PE was between 0.1% and 0.3%. The highest incidence (0.3%) was associated with esophagectomy and acute pan‐peritonitis surgery.

3.2. Patient characteristics {#ags312275-sec-0012}
----------------------------

The patient population represented in the NCD had an average age of 68.6 years. The mean body mass index (BMI) of the population was 22.1 kg/m^2^. In the VTE‐positive group, BMI and creatinine levels were significantly higher and the estimated glomerular filtration rate was lower. Regarding the intra‐operative factors, the operation time was significantly longer and the loss of blood was greater in the PE‐positive group (Table [2](#ags312275-tbl-0002){ref-type="table"}).

###### 

Patient characteristics (2011‐2013) (N = 382 124)

                            Total   VTE (−)   VTE (+)   *P*        PE (−)   PE (+)   *P*
  ------------------------- ------- --------- --------- ---------- -------- -------- ----------
  Mean age                  68.6    68.6      70.7      0.003      68.6     70.3     0.198
  Length of stay (d)        28.2    28.2      47.9      \<0.0001   28.2     45.6     \<0.0001
  Length of ICU stay (d)    3.0     3.0       7.8       \<0.0001   3.0      7.4      \<0.0001
  Height (cm)               159.7   159.7     158.6     0.243      159.7    159.1    0.367
  Weight (kg)               56.7    56.7      57.6      0.504      56.7     58.8     0.547
  BSA                       1.58    1.58      1.58      0.762      1.58     1.60     0.97
  BMI (kg/m^2^)             22.1    22.1      22.9      \<0.0001   22.1     23.2     \<0.0001
  Creatinine (mg/dL)        0.89    0.89      1.00      \<0.0001   0.89     0.98     0.001
  eGFR                      60.1    60.1      58.0      \<0.0001   60.1     58.3     0.234
  Anesthesia time (min)     339.6   339.4     404.6     \<0.0001   339.5    403.8    \<0.0001
  Operation time (min)      277.3   277.1     336.4     \<0.0001   277.2    338.2    \<0.0001
  Operation bleeding (mL)   432.9   431.8     760.6     \<0.0001   432.5    731.5    \<0.0001

Abbreviations: BMI, body mass index; BSA, body surface area; eGFR, estimated glomerular filtration rate; PE, pulmonary embolism; VTE, venous thromboembolism.
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3.3. Risk profile associated with postoperative VTE and PE {#ags312275-sec-0013}
----------------------------------------------------------

There were no significant differences in the profiles of the variables between the data set and validation sets. All risk model data were derived from multivariable analysis.

3.4. Risk factors for VTE and PE {#ags312275-sec-0014}
--------------------------------

The final logistic regression models with odds ratios (ORs) were summarized. The 95% confidence intervals (CIs), statistical significance of each model and β‐coefficient intercept are presented.

The risk factor for VTE using the pre and intra‐operation factors included 23 factors (Table [3](#ags312275-tbl-0003){ref-type="table"}). The types of surgical procedure were among the top risk factors. The top three highest ORs were for esophagectomy (3.843), pancreaticoduodenectomy (2.349), and hepatectomy performed for \>1 segment apart from the lateral segment (2.182). There was little relationship between sex (male, 0.759), disseminated cancer (1.321), or BMI \>30 kg/m^2^ (1.442), which have previously been considered high‐risk factors for VTE.

###### 

The risk for VTE associated with pre‐ and intra‐operative factors (N = 382 124)

                                                                         VTE risk preOP + OP   *P*                   
  ---------------------------------------------------------------------- --------------------- ------- ------------- ---------
  Age category[a](#ags312275-note-0004){ref-type="fn"}                   0.184                 1.202   1.111‐1.302   \<0.001
  Intrahepatic bile duct cancer                                          0.513                 1.670   1.083‐2.573   0.02
  ASA (grade3‐5)                                                         0.316                 1.371   1.186‐1.585   \<0.001
  No tumor                                                               −0.19                 0.827   0.655‐1.044   0.11
  Hepatectomy performed for \>1 segment apart from the lateral segment   0.780                 2.182   1.782‐2.672   \<0.001
  Pancreaticoduodenectomy                                                0.854                 2.349   1.973‐2.796   \<0.001
  Esophagectomy                                                          1.346                 3.843   3.166‐4.664   \<0.001
  Sex (male)                                                             −0.276                0.759   0.679‐0.847   \<0.001
  Emergent surgery                                                       0.656                 1.927   1.523‐2.438   \<0.001
  ADL pre‐operation any assistance                                       0.210                 1.234   1.039‐1.467   0.017
  Pre‐operation ventilation                                              0.635                 1.887   1.326‐2.687   \<0.001
  Hypertension any                                                       0.146                 1.157   1.033‐1.295   0.012
  Recent cerebrovascular disease                                         0.613                 1.846   1.162‐2.933   0.009
  Disseminated cancer                                                    0.278                 1.321   1.034‐1.688   0.026
  Chronic steroid use                                                    0.534                 1.706   1.245‐2.339   0.001
  Weight loss over 10%                                                   0.426                 1.531   1.270‐1.847   \<0.001
  Bleeding disorder (any)                                                0.486                 1.627   1.350‐1.960   \<0.001
  Systemic sepsis                                                        0.771                 2.162   1.717‐2.722   \<0.001
  BMI \>25 kg/m^2^                                                       0.585                 1.794   1.572‐2.048   \<0.001
  BMI \>30 kg/m^2^                                                       0.366                 1.442   1.095‐1.899   0.009
  Platelet count \>350 000/μL                                            0.212                 1.236   1.046‐1.462   0.013
  Serum albumin level \<4 mg/dL                                          0.425                 1.530   1.359‐1.723   \<0.001
  PT‐INR \>0.9                                                           0.340                 1.405   1.047‐1.884   0.023

Abbreviations: ADL, activities of daily living; ASA, American Society of Anesthesiologists Physical Status Classification; BMI body mass index; CI, confidence interval; CRP, C‐reactive protein; OP, operation; preOP, preoperation; PT‐INR, prothrombin time/international normalized ratio; VTE, venous thromboembolism.

The variables of age were categorized into four groups, which is less than 39, 40‐59, 60‐74, and more than 75 y. Therefore, this odds ratio indicates an alteration of relative risk for one unit of increase in the age category.
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Similarly, 39 factors were evaluated as risk factors for VTE using pre‐, intra‐, and postoperative factors (Tables [4](#ags312275-tbl-0004){ref-type="table"} and 7). The highest ORs were again for type of surgery, with esophagectomy (2.439) having the highest OR even when including postoperative factors, followed by sepsis (2.305), prolonged ventilation \<48 hours (2.041), and readmission within 30 days (1.994).

###### 

The risk for VTE associated with pre‐, intra‐, and postoperative factors (N: 382 124)

                                                                         VTE risk preOP + OP + Post OP   *P*                   
  ---------------------------------------------------------------------- ------------------------------- ------- ------------- ---------
  Age category                                                           0.154                           1.166   1.076‐1.264   \<0.001
  Intrahepatic bile duct cancer                                          0.353                           1.424   0.912‐2.221   0.114
  ASA (grade3‐5)                                                         0.13                            1.138   0.978‐1.325   0.097
  No tumor                                                               −0.3                            0.741   0.584‐0.94    0.014
  Hepatectomy performed for \>1 segment apart from the lateral segment   0.674                           1.962   1.587‐2.426   \<0.001
  Pancreaticoduodenectomy                                                0.483                           1.621   1.33‐1.977    \<0.001
  Esophagectomy                                                          0.892                           2.439   1.987‐2.993   \<0.001
  Sex (male)                                                             −0.454                          0.635   0.567‐0.711   \<0.001
  Emergent surgery                                                       0.478                           1.613   1.266‐2.054   \<0.001
  Activities of daily living pre‐operation any assistance                0.012                           1.012   0.848‐1.208   0.846
  Pre‐operation ventilation                                              0.1                             1.105   0.767‐1.592   0.492
  Hypertension (any)                                                     0.1                             1.106   0.986‐1.239   0.085
  Recent cerebrovascular disease                                         0.515                           1.674   1.041‐2.689   0.031
  Disseminated cancer                                                    0.202                           1.224   0.955‐1.569   0.111
  Chronic steroid use                                                    0.395                           1.485   1.077‐2.048   0.014
  Weight loss over 10%                                                   0.285                           1.33    1.098‐1.609   0.003
  Bleeding disorder (any)                                                0.32                            1.377   1.136‐1.669   0.001
  Systemic sepsis                                                        0.122                           1.13    0.885‐1.443   0.276
  BMI \>25 kg/m^2^                                                       0.473                           1.604   1.403‐1.835   \<0.001
  BMI \>30 kg/m^2^                                                       0.239                           1.27    0.96‐1.68     0.1
  Platelet count \>350 000/μL                                            0.25                            1.284   1.084‐1.52    0.004
  Serum albumin level \<4 mg/dL                                          0.328                           1.388   1.231‐1.566   \<0.001
  PT‐INR \<0.9                                                           0.371                           1.449   1.078‐1.949   0.014
  Operation time quartile over[a](#ags312275-note-0006){ref-type="fn"}   0.472                           1.603   1.43‐1.797    \<0.001
  Reoperation                                                            0.565                           1.76    1.497‐2.069   \<0.001
  Overall SSI                                                            0.37                            1.447   1.236‐1.695   \<0.001
  Anastomotic leak                                                       0.211                           1.235   1.028‐1.484   0.024
  Pancreatic fistula grade ABC                                           0.251                           1.285   1.023‐1.616   0.033
  Pneumonia                                                              0.184                           1.202   0.996‐1.451   0.011
  Unplanned intubation                                                   0.34                            1.406   1.122‐1.761   0.004
  Prolonged ventilation \>48 h                                           0.714                           2.041   1.616‐2.58    \<0.001
  Urinary tract infection                                                0.61                            1.84    1.437‐2.357   \<0.001
  CNS occurrences any                                                    0.226                           1.254   0.998‐1.575   0.05
  Cardiac occurrences any                                                0.65                            1.915   1.485‐2.469   \<0.001
  Transfusion any                                                        0.348                           1.416   1.185‐1.692   \<0.001
  Septic shock                                                           0.341                           1.406   1.099‐1.8     0.008
  Sepsis                                                                 0.835                           2.305   1.81‐2.936    \<0.001
  SIRS                                                                   0.605                           1.832   1.424‐2.356   \<0.001
  Readmission within 30 d                                                0.69                            1.994   1.525‐2.608   \<0.001

Abbreviations: ASA, American Society of Anesthesiologists Physical Status Classification; BMI, Body mass index; CNS, central nervous system; postOP, postoperation; PT‐INR, prothrombin time/international normalized ratio; SIRS, systemic inflammatory response syndrome; VTE, venous thromboembolism.

Details of the time quartile over that shown in Table [7](#ags312275-tbl-0007){ref-type="table"}.
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Similarly, 18 pre‐ and intra‐operative factors were evaluated for PE (Tables [5](#ags312275-tbl-0005){ref-type="table"} and 7), and the results were similar to those for VTE.

###### 

The risk for pulmonary embolism (PE) with pre‐ and intra‐operative factors (N = 382 124)

                                                                         PE risk preOP + OP   *P*                   
  ---------------------------------------------------------------------- -------------------- ------- ------------- ---------
  Age category[a](#ags312275-note-0010){ref-type="fn"}                   0.223                1.25    1.112‐1.405   \<0.001
  Esophagectomy                                                          1.173                3.231   2.313‐4.513   \<0.001
  ASA (grades 3‐5)                                                       0.327                1.387   1.113‐1.729   0.004
  Low anterior resection                                                 0.398                1.488   1.14‐1.943    0.003
  Hepatectomy performed for \>1 segment apart from the lateral segment   0.965                2.626   1.957‐3.523   \<0.001
  Total gastrectomy                                                      0.355                1.427   1.106‐1.84    0.006
  Pancreaticoduodenectomy                                                0.905                2.473   1.867‐3.275   \<0.001
  Sex (male)                                                             −0.286               0.752   0.634‐0.891   0.001
  Emergent surgery                                                       0.49                 1.633   1.205‐2.214   0.002
  Ascites                                                                0.379                1.461   1.051‐2.032   0.024
  Chronic steroid use                                                    0.596                1.815   1.107‐2.976   0.018
  Weight loss over 10%                                                   0.512                1.669   1.263‐2.206   \<0.001
  Preop transfusions                                                     0.554                1.739   1.24‐2.44     0.001
  Systemic sepsis                                                        0.712                2.037   1.412‐2.939   \<0.001
  Body mass index \>25 kg/m^2^                                           0.76                 2.138   1.784‐2.563   \<0.001
  Platelet count \>350 000/μL                                            0.292                1.339   1.045‐1.717   0.021
  Serum albumin level \<4 mg/dL                                          0.372                1.45    1.211‐1.737   \<0.001
  Operation time quartile over[a](#ags312275-note-0010){ref-type="fn"}   0.651                1.918   1.621‐2.269   \<0.001

Abbreviations: ASA, American Society of Anesthesiologists Physical Status Classification; OP, operation; preOP, preoperation.

Details of the time quartile over that shown in Table [7](#ags312275-tbl-0007){ref-type="table"}.
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For PE, 28 pre‐, intra‐, and postoperative factors were selected (Tables [6](#ags312275-tbl-0006){ref-type="table"} and [7](#ags312275-tbl-0007){ref-type="table"}). The highest OR was for any cardiac occurrence (2.926). Unplanned intubation (2.396) was the fourth highest. Chest events were recognized as high risk, which differed from risks for DVT.

###### 

The risk for PE with pre‐, intra‐, and postoperative factors (N = 382 124)

                                                                         PE risk preOP + OP + postOP   *P*                   
  ---------------------------------------------------------------------- ----------------------------- ------- ------------- ---------
  Age category                                                           0.122                         1.129   1.003‐1.271   0.044
  Esophagectomy                                                          0.557                         1.746   1.227‐2.483   0.002
  ASA (grade3‐5)                                                         0.043                         1.044   0.829‐1.315   0.715
  LAR                                                                    0.356                         1.428   1.088‐1.875   0.01
  Hepatectomy performed for \>1 segment apart from the lateral segment   0.693                         2       1.478‐2.705   \<0.001
  Total gastrectomy                                                      0.129                         1.137   0.876‐1.476   0.334
  Pancreaticoduodenectomy                                                0.354                         1.425   1.034‐1.964   0.03
  Sex (male)                                                             −0.44                         0.644   0.542‐0.765   \<0.001
  Emergent surgery                                                       0.169                         1.184   0.866‐1.618   0.291
  Ascites                                                                0.204                         1.226   0.88‐1.709    0.228
  Chronic steroid use                                                    0.476                         1.609   0.978‐2.649   0.061
  Weight loss over 10%                                                   0.387                         1.473   1.112‐1.951   0.007
  preOP transfusions                                                     0.331                         1.392   0.987‐1.964   0.059
  Systemic sepsis                                                        0.207                         1.23    0.846‐1.79    0.279
  BMI \>25 kg/m^2^                                                       0.684                         1.982   1.651‐2.38    \<0.001
  Platelet count \>350 000/μL                                            0.325                         1.384   1.077‐1.777   0.011
  Serum albumin level \<4 mg/dL                                          0.25                          1.284   1.07‐1.541    0.007
  Endoscopic surgery                                                     −0.446                        0.64    0.495‐0.827   0.001
  Operation time quartile over[a](#ags312275-note-0010){ref-type="fn"}   0.533                         1.705   1.433‐2.027   \<0.001
  Reoperation                                                            0.56                          1.75    1.371‐2.235   \<0.001
  Anastomotic leak                                                       0.277                         1.319   1.013‐1.717   0.04
  Pancreatic fistula                                                     0.478                         1.614   1.159‐2.247   0.005
  Pneumonia                                                              0.499                         1.647   1.253‐2.166   \<0.001
  Unplanned intubation                                                   0.874                         2.396   1.701‐3.374   \<0.001
  Prolonged ventilation \>48 h                                           1.018                         2.766   1.959‐3.906   \<0.001
  Urinary tract infection                                                0.51                          1.665   1.133‐2.446   0.009
  Cardiac adverse events (any)                                           1.074                         2.926   2.138‐4.005   \<0.001
  Readmission within 30 d                                                1.037                         2.82    1.975‐4.027   \<0.001

Abbreviations: ASA, American Society of Anesthesiologists Physical Status Classification; OP, operation; postop, postoperation; preOP, preoperation; BMI, body mass index; CI, confidence interval; LAR, low anterior resection; PE pulmonary embolism.

Details of the time quartile over that shown in Table [7](#ags312275-tbl-0007){ref-type="table"}.
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###### 

Duration of surgical procedures

                                  Mean (min)   Median (min)   Quartile over (min)
  ------------------------------- ------------ -------------- ---------------------
  Gastrectomy                     187          242            305
  Total gastrectomy               210          267            338
  Hepatectomy                     393          367            477
  Esophagectomy                   481          469            573
  Right hemicolectomy             203          188            245
  Low anterior resection          275          254            335
  Pancreaticoduodenectomy         470          455            547
  Acute pan‐peritonitis surgery   129          115            160
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3.5. Model performance {#ags312275-sec-0015}
----------------------

To evaluate model performance, the C‐index (a measure of model discrimination), which was the area under the ROC curve, was calculated for each data set in the models (Fig. [1](#ags312275-fig-0001){ref-type="fig"}). The C‐indices of the model for VTE and PE using pre‐ and intra‐operative factors were 0.717 (95% CI: 0.704‐0.731; *P *\<* *0.007) and 0.718 (95% CI: 0.696‐0.739; *P *\<* *0.011), respectively. The C‐indices of the model for VTE and PE using pre‐, intra‐, and postoperative factors were 0.820 (95% CI: 0.809‐0.832; *P *\<* *0.006) and 0.825 (95% CI: 0.806‐0.843; *P *\<* *0.009), respectively.

![Receiver operating characteristic curve and area under the curve (AUC) of each data set. OP, operation; VTE, for venous thromboembolism; PE, pulmonary embolism](AGS3-3-534-g001){#ags312275-fig-0001}

In the validation set models, the C‐indices of the model for VTE and PE using pre‐ and intra‐operative factors were 0.709 (95% CI: 0.687‐0.730; *P *\<* *0.011) and 0.720 (95% CI: 0.687‐0.752; *P *\<* *0.017), respectively. The C‐indices of the model for VTE and PE using pre‐, intra‐, and postoperative factors were 0.814 (95% CI: 0.795‐0.832; *P *\<* *0.009) and 0.797 (95% CI: 0.767‐0.827; *P *\<* *0.015), respectively (ROC depicted in Fig. [1](#ags312275-fig-0001){ref-type="fig"}). These data sets indicate the good discriminatory performance of the model.

3.6. Calibration of the model {#ags312275-sec-0016}
-----------------------------

The predicted rate of VTE or PE using the risk model was highly consistent with the actual rate of onset in the validation data from the low‐risk group through to the high‐risk group (Fig. [2](#ags312275-fig-0002){ref-type="fig"}).

![The calibration of the model for venous thromboembolism (VTE) or pulmonary embolism (PE). OP, operation](AGS3-3-534-g002){#ags312275-fig-0002}

4. DISCUSSION {#ags312275-sec-0017}
=============

In this study, we used a database that included the largest number of registrations in Japan to investigate the frequency and risk factors for perioperative, symptomatic VTE and PE in clinical practice. The number of cases was 516 217, which was considerably larger than the number of cases in past reports.

In the eight surgical procedures assessed, the frequency of PE was 0.1%‐0.3%. The incidence was highest with the pan‐peritonitis operation and esophagectomy. The frequency of DVT was also 0.1%‐0.7%. The surgical procedures with the highest incidence of DVT were the pan‐peritonitis operation and esophagectomy. A previous study of patients in Japan reported that the incidence of perioperative PE during general surgery was 0.33%.[13](#ags312275-bib-0013){ref-type="ref"} The results of our study did not differ much from this past report. On the other hand, Rogers et al[14](#ags312275-bib-0014){ref-type="ref"} reported that the frequency of VTE was 0.93% after gastroenterological surgery in NSQIP data. This frequency is a little higher than the data from Japan and could be due to racial differences.

In this study, the frequency of PE was classified as low risk or high risk according to the 7th American College of Chest Physicians guidelines and Japan\'s guidelines. In these guidelines, cancer operations are classified as high risk. However, in the present study, among the surgical procedures, the risk was lower than that reported in the guidelines. However, the Japanese VTE risk score, the Wells score,[15](#ags312275-bib-0015){ref-type="ref"} and the Caprini score,[16](#ags312275-bib-0016){ref-type="ref"} which use Western VTE guidelines, do not include detail on the risk according to different types of surgical procedures. We found little relationship between our risk factor findings for VTE and those reported in the past. We found a seven‐fold difference in the frequency of PE based on the different surgical procedures. Moreover, differences in the risk factors for VTE and PE according to the type of surgical procedure were observed. These results show that the type of surgical procedure and the surgical site are important when considering the VTE risk factors.

In this study, we developed two different risk models to predict risk factors for VTE and PE. One used pre‐ and intra‐operative factors, while the other also included postoperative factors. The pre‐ and intra‐operative factors were sufficient to decide on peri‐operative prophylaxis. However, if risk factors were added after the operation, the risk of VTE and PE may change, although in past reports postoperative risk factors were only included in a few analyses of risk for VTE.

Venous thromboembolism and PE risk factors were different whether or not postoperative factors were added to the model. Intubation for more than 48 hours and re‐hospitalization were regarded as high‐risk factors for VTE, and chest events were recognized as risk factors for PE. These results show that it is necessary to reconsider the prophylaxis if complications occur after surgery, especially breathing and cardiac complications, which are important risk factors for PE.

This study has some limitations. We could not detect symptomatic versus asymptomatic VTE in the NCD data.

Prophylaxis has a great influence on the postoperative onset of VTE. However, the NCD has no information on what VTE prophylaxis was provided. Anticoagulant prophylaxis for VTE would provide important information about bleeding complications, but the NCD data does not include information about bleeding events associated with anticoagulant prophylaxis. The analysis of risk factors for VTE would be more accurate if the NCD database included such information and the kind of prophylaxis that was used.

In conclusion, the frequency of VTE and PE differed according to the type of surgical procedure (0.1%‐0.3% and 0.1%‐0.7%, respectively). Esophagectomy and pancreaticoduodenectomy were strong risk factors for VTE and PE. Also, the risk of VTE and PE also differed according to the type of surgical procedure. We recommend that these differences be reflected in the VTE risk score. By adding postoperative factors, VTE and PE risk factors were changed. It may be necessary to reconsider the prophylaxis if complications occur after surgery, especially breathing and cardiac complications, which are important postoperative risk factors for PE.
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